Literature DB >> 18799311

Synthesis and immunostimulatory properties of the phosphorothioate analogues of cdiGMP.

Hongbin Yan1, Xiaolu Wang, Rhonda KuoLee, Wangxue Chen.   

Abstract

The synthesis of mono- and bisphosphorothioate analogues of 3',5'-cyclic diguanylic acid (cdiGMP) via the modified H-phosphonate chemistry is reported. The immunostimulatory properties of these analogues were compared with those of cdiGMP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799311     DOI: 10.1016/j.bmcl.2008.08.088

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade.

Authors:  Juan Fu; David B Kanne; Meredith Leong; Laura Hix Glickman; Sarah M McWhirter; Edward Lemmens; Ken Mechette; Justin J Leong; Peter Lauer; Weiqun Liu; Kelsey E Sivick; Qi Zeng; Kevin C Soares; Lei Zheng; Daniel A Portnoy; Joshua J Woodward; Drew M Pardoll; Thomas W Dubensky; Young Kim
Journal:  Sci Transl Med       Date:  2015-04-15       Impact factor: 17.956

Review 2.  Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants.

Authors:  Thomas W Dubensky; David B Kanne; Meredith L Leong
Journal:  Ther Adv Vaccines       Date:  2013-11

3.  Synthesis of c-di-GMP analogs with thiourea, urea, carbodiimide, and guanidinium linkages.

Authors:  Barbara L Gaffney; Roger A Jones
Journal:  Org Lett       Date:  2013-12-06       Impact factor: 6.005

4.  Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

Authors:  Leticia Corrales; Laura Hix Glickman; Sarah M McWhirter; David B Kanne; Kelsey E Sivick; George E Katibah; Seng-Ryong Woo; Edward Lemmens; Tamara Banda; Justin J Leong; Ken Metchette; Thomas W Dubensky; Thomas F Gajewski
Journal:  Cell Rep       Date:  2015-05-07       Impact factor: 9.423

5.  A kinase-cGAS cascade to synthesize a therapeutic STING activator.

Authors:  John A McIntosh; Zhijian Liu; Brian M Andresen; Nastaran Salehi Marzijarani; Jeffrey C Moore; Nicholas M Marshall; Margie Borra-Garske; Jennifer V Obligacion; Patrick S Fier; Feng Peng; Jacob H Forstater; Matthew S Winston; Chihui An; Wonsuk Chang; Jongwon Lim; Mark A Huffman; Steven P Miller; Fuh-Rong Tsay; Michael D Altman; Charles A Lesburg; Dietrich Steinhuebel; B Wesley Trotter; Jared N Cumming; Alan Northrup; Xiaodong Bu; Benjamin F Mann; Mirlinda Biba; Kaori Hiraga; Grant S Murphy; Joshua N Kolev; Amanda Makarewicz; Weilan Pan; Iman Farasat; Rachel S Bade; Kevin Stone; Da Duan; Oscar Alvizo; Donovan Adpressa; Erik Guetschow; Erik Hoyt; Erik L Regalado; Steve Castro; Nelo Rivera; Joseph P Smith; Fengqiang Wang; Alejandro Crespo; Deeptak Verma; Stephanus Axnanda; Zachary E X Dance; Paul N Devine; David Tschaen; Keith A Canada; Paul G Bulger; Benjamin D Sherry; Matthew D Truppo; Rebecca T Ruck; Louis-Charles Campeau; David Jonathan Bennett; Guy R Humphrey; Kevin R Campos; Matthew L Maddess
Journal:  Nature       Date:  2022-03-16       Impact factor: 49.962

Review 6.  Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.

Authors:  Kyle M Garland; Taylor L Sheehy; John T Wilson
Journal:  Chem Rev       Date:  2022-02-02       Impact factor: 60.622

Review 7.  Biomolecular Mechanisms of Pseudomonas aeruginosa and Escherichia coli Biofilm Formation.

Authors:  Garry Laverty; Sean P Gorman; Brendan F Gilmore
Journal:  Pathogens       Date:  2014-07-18

8.  2'-Fluoro-c-di-GMP as an oral vaccine adjuvant.

Authors:  Jia Li; Rhonda Kuo Lee; Wangxue Chen; Hongbin Yan
Journal:  RSC Adv       Date:  2019-12-16       Impact factor: 4.036

Review 9.  Nanodelivery of STING agonists against cancer and infectious diseases.

Authors:  Jiarong Zhou; Christian J Ventura; Ronnie H Fang; Liangfang Zhang
Journal:  Mol Aspects Med       Date:  2021-08-02

Review 10.  Small Molecules Drive Big Improvements in Immuno-Oncology Therapies.

Authors:  Bayard R Huck; Lisa Kötzner; Klaus Urbahns
Journal:  Angew Chem Int Ed Engl       Date:  2018-02-22       Impact factor: 15.336

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.